Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure

Pharmacotherapy

Volumn 34, Issue 8, 2014, Pages 882-887

  Kissling, Kevin T ^a   Pickworth, Kerry K ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

combination therapy; heart failure; thiazide diuretics

Indexed keywords

CHLOROTHIAZIDE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; DIURETIC AGENT; LOOP DIURETIC AGENT;

ADULT; AGED; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONTINUOUS INFUSION; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TEACHING HOSPITAL; URINE VOLUME; VERY ELDERLY; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; CHLOROTHIAZIDE; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; HYDROCHLOROTHIAZIDE; HYPOKALEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 84906101913     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1456     Document Type: Conference Paper

References (11)

1. Heidenreich PA, Torgdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123: 933-44.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-209.
3. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240-327.
4. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive heart failure practice guideline. J Card Fail 2010; 16: e1-194.
5. Jentzer JC, DeWald TA, Hernandez AF,. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010; 56: 1527-34.
6. Ellison DH,. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991; 114: 886-94.
7. Mouallem M, Brif I, Mayan H, Farfel Z,. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Int J Cardiol 1995; 50: 89-94.
8. Dormans TPJ, Gerlag PGG,. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996; 17: 1867-74.
9. Red Book Online. Micromedex Healthcare Series Website. Available from http://www.thomsonhc.com/home. Accessed June 13, 2012.
10. Borhani NO,. Chlorothiazide and hydrochlorothiazide: a comparative study of their hypotensive, saluretic, and hyperuricemic action. Ann Intern Med 1960; 53: 342-58.
11. Black WD, Shiner PT, Roman J,. Severe electrolyte disturbances associated with metolazone and furosemide. South Med J 1978; 71: 380-1.